Literature DB >> 6490832

Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses.

S W Mitchell, J B McCormick.   

Abstract

Clinical specimens from patients infected with Lassa, Ebola, or Marburg virus may present a serious biohazard to laboratory workers. We have examined the effects of heat, alteration of pH, and gamma radiation on these viruses in human blood and on the electrolytes, enzymes, and coagulation factors measured in laboratory tests that are important in the care of an infected patient. Heating serum at 60 degrees C for 1 h reduced high titers of these viruses to noninfectious levels without altering the serum levels of glucose, blood urea nitrogen, and electrolytes. Dilution of blood in 3% acetic acid, diluent for a leukocyte count, inactivated all of these viruses. All of the methods tested for viral inactivation markedly altered certain serum proteins, making these methods unsuitable for samples that are to be tested for certain enzyme levels and coagulation factors.

Entities:  

Mesh:

Year:  1984        PMID: 6490832      PMCID: PMC271356          DOI: 10.1128/jcm.20.3.486-489.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Protein losses during sterilizing by filtration.

Authors:  R J Hawker; L M Hawker
Journal:  Lab Pract       Date:  1975-12

2.  Vervet monkey disease: studies on some physical and chemical properties of the causative agent.

Authors:  E T Bowen; D I Simpson; W F Bright; I Zlotnik; D M Howard
Journal:  Br J Exp Pathol       Date:  1969-08

3.  Physical and chemical methods of inactivating Lassa virus.

Authors:  G Lloyd; E T Bowen; J H Slade
Journal:  Lancet       Date:  1982-05-08       Impact factor: 79.321

4.  Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire.

Authors:  K M Johnson; J V Lange; P A Webb; F A Murphy
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

5.  Filoviridae: a taxonomic home for Marburg and Ebola viruses?

Authors:  M P Kiley; E T Bowen; G A Eddy; M Isaäcson; K M Johnson; J B McCormick; F A Murphy; S R Pattyn; D Peters; O W Prozesky; R L Regnery; D I Simpson; W Slenczka; P Sureau; G van der Groen; P A Webb; H Wulff
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

6.  Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation.

Authors:  L H Elliott; J B McCormick; K M Johnson
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

7.  Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus.

Authors:  S M Buckley; J Casals
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

8.  Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus.

Authors:  D H Walker; K M Johnson; J V Lange; J J Gardner; M P Kiley; J B McCormick
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

9.  Adherence of bacteria, yeast, blood cells, and latex spheres to large-porosity membrane filters.

Authors:  C H Zierdt
Journal:  Appl Environ Microbiol       Date:  1979-12       Impact factor: 4.792

  9 in total
  36 in total

Review 1.  Laboratory Diagnosis of Lassa Fever.

Authors:  Vanessa Raabe; Jeffrey Koehler
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

2.  Change in blood test after irradiation with high doses for inactivation of Lassa virus.

Authors:  K Eberlein; G Hintereder; S Schilling; C Rödel; L Jüling-Pohlit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-26       Impact factor: 3.267

3.  Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.

Authors:  Sophie J Smither; Simon A Weller; Amanda Phelps; Lin Eastaugh; Sarah Ngugi; Lyn M O'Brien; Jackie Steward; Steve G Lonsdale; Mark S Lever
Journal:  J Clin Microbiol       Date:  2015-07-15       Impact factor: 5.948

4.  Effect of viral decontamination measures on Wright-stained blood smears.

Authors:  Jay N Lozier; Katherine R Calvo
Journal:  Blood       Date:  2015-02-19       Impact factor: 22.113

5.  Gamma Irradiation as an Effective Method for Inactivation of Emerging Viral Pathogens.

Authors:  Friederike Feldmann; W Lesley Shupert; Elaine Haddock; Barri Twardoski; Heinz Feldmann
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

Review 6.  Diagnosis of Ebola Virus Disease: Past, Present, and Future.

Authors:  M Jana Broadhurst; Tim J G Brooks; Nira R Pollock
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

7.  Ebola Infection and Diabetes Mellitus.

Authors:  Sora Yasri; Viroj Wiwanitkit
Journal:  Iran J Pathol       Date:  2016

8.  Ebola Virus Shedding and Transmission: Review of Current Evidence.

Authors:  Pauline Vetter; William A Fischer; Manuel Schibler; Michael Jacobs; Daniel G Bausch; Laurent Kaiser
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

9.  Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests.

Authors:  Maiken Worsøe Rosenstierne; Helen Karlberg; Karoline Bragstad; Gunnel Lindegren; Malin Lundahl Stoltz; Cristiano Salata; Anne-Marte Bakken Kran; Susanne Gjeruldsen Dudman; Ali Mirazimi; Anders Fomsgaard
Journal:  J Clin Microbiol       Date:  2016-07-27       Impact factor: 5.948

10.  Ebola Virus Inactivation by Detergents Is Annulled in Serum.

Authors:  Jeroen J A van Kampen; Andrei Tintu; Henk Russcher; Pieter L A Fraaij; Chantal B E M Reusken; Mikel Rijken; Jaap J van Hellemond; Perry J J van Genderen; Rob Koelewijn; Menno D de Jong; Elaine Haddock; Robert J Fischer; Vincent J Munster; Marion P G Koopmans
Journal:  J Infect Dis       Date:  2017-10-17       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.